Table 1. Demographic and clinical characteristics of all PLHIV.
| Characteristic | All PLHIV (n = 1,595) | Inpatient PLHIV (n = 968) | Outpatient PLHIV (n = 627) |
|---|---|---|---|
| Demographic and clinical characteristics | |||
| Age—years | 36.6 (30; 43) | 35 (30; 42) | 38 (31; 44) |
| Female sex | 939 (59%) | 523 (54%) | 416 (66%) |
| Positive WHO TB symptom screen | 1,498 (94%) | 933 (96%) | 565 (90%) |
| History of TB | 536 (34%) | 439 (45%) | 97 (16%) |
| Antiretroviral therapy | 558 (35%) | 394 (41%) | 164 (26%) |
| CD4 count—cells/μl | 126 (42; 302) | 86 (33; 190) | 249 (91; 477) |
| Distribution in diagnostic categories | |||
| Definite TB | 724 (45%) | 600 (62%) | 124 (20%) |
| Possible TB | 110 (7%) | 91 (9%) | 19 (3%) |
| Not TB | 761 (48%) | 277 (29%) | 484 (77%) |
| CD4 count (cells/μl) | |||
| 0 to 100 | 677 (43%) | 516 (53%) | 161 (26%) |
| 101 to 200 | 319 (20%) | 216 (22%) | 103 (16%) |
| >200 | 581 (36%) | 231 (24%) | 350 (56%) |
| Unknown | 18 (1%) | 5 (1%) | 13 (2%) |
| Outcome | |||
| Died within 2–3 months | 119 (7%) | 105 (11%) | 14 (2%) |
| Alive | 1,354 (85%) | 810 (84%) | 544 (87%) |
| Lost to follow-up | 35 (2%) | 16 (2%) | 19 (3%) |
| No follow-up done/required* | 87 (6%) | 37 (4%) | 50 (8%) |
Data are given as median (interquartile range) or number (percent).
*No follow-up done/required: empty follow-up field in case report form of cohort 4 or no follow-up required at other sites.
PLHIV, people living with HIV; TB, tuberculosis; WHO, World Health Organization.